T Decker

Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27

C. Miething, C. Peschel, J. Duyster, 2002, Leukemia.

Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice.

C. Barlow, A. Wynshaw-Boris, L. Castilla, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.

C. Peschel, T. Decker, F. Schneller, 2000, Blood.

A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity.

T. Decker, M. Lohmann‐Matthes, M L Lohmann-Matthes, 1988, Journal of immunological methods.